BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28246015)

  • 1. Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer.
    Zhu M; Yan C; Ren C; Huang X; Zhu X; Gu H; Wang M; Wang S; Gao Y; Ji Y; Miao X; Yang M; Chen J; Du J; Huang T; Jiang Y; Dai J; Ma H; Zhou J; Wang Z; Hu Z; Ji G; Zhang Z; Shen H; Shi Y; Jin G
    Gastroenterology; 2017 Jun; 152(8):2011-2021. PubMed ID: 28246015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
    Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
    Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
    Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
    Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
    Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
    Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
    Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells.
    Zhang YQ; Pei JH; Shi SS; Guo XS; Cui GY; Li YF; Zhang HP; Hu WQ
    Biomed Pharmacother; 2019 Mar; 111():76-85. PubMed ID: 30576937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
    Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
    Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.
    Cai P; Lu Z; Wu J; Qin X; Wang Z; Zhang Z; Zheng L; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2643-2654. PubMed ID: 31692043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
    Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
    Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.